Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2406325121Source: DataRank Database

In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 1.22)OA: hybridTopics (51)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Chang Yang ORCID,Yuanjian Huang ORCID,Dan Su ORCID,Chao Wang ORCID,Lori Wilson ORCID

Live enrichment

PubMed:39298484 OpenAlex:https://openalex.org/W4402626524

Cancer Prevention and Research Institute of Texas

Grant: RP160667 RP180813

HHS | NIH | National Cancer Institute

Grant: CA193124 CA210929 CA216911 CA216437 CA274234 CA275712

HHS | National Institutes of Health

Grant: R35GM130119

NCI NIH HHS

Grant: R01 CA275712

NCI NIH HHS

Grant: P30 CA125123

NIH HHS

Grant: S10 OD023469

NCI NIH HHS

Grant: R35 CA274234

NCI NIH HHS

Grant: R01 CA216911

NCI NIH HHS

Grant: P01 CA193124

NCI NIH HHS

Grant: P30 CA016672

NCI NIH HHS

Grant: R01 CA210929

NIH HHS

Grant: S10 OD025240

NEI NIH HHS

Grant: P30 EY002520

NCI NIH HHS

Grant: R01 CA216437

NCRR NIH HHS

Grant: S10 RR024574

FWCI

1.22

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://www.pnas.org/doi/pdf/10.1073/pnas.2406325121

publisherhttps://www.pnas.org/doi/pdf/10.1073/pnas.2406325121

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2406325121

journalhttps://doi.org/10.1073/pnas.2406325121

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39298484

Fields of Study

Immunotherapy and Immune ResponsesImmune cells in cancerImmune Cell Function and InteractionAnimalsFemaleHumansMiceCell Line, TumorClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsGene Expression Regulation, NeoplasticImmunotherapyInterferon-gammaTriple Negative Breast NeoplasmsTumor EscapeTumor MicroenvironmentBasic Helix-Loop-Helix Proteins

MeSH Terms

AnimalsFemaleHumansImmunotherapyInterferon-gammaGene Expression Regulation, NeoplasticTumor EscapeCell Line, TumorMiceBasic Helix-Loop-Helix ProteinsTumor MicroenvironmentClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsTriple Negative Breast Neoplasms

Keywords

Immune systemCRISPRImmunotherapyBiologyBreast cancerCancer researchTriple-negative breast cancerTumor microenvironmentContext (archaeology)CancerTranscriptomeCancer immunotherapyImmunologyGeneGene expressionGeneticsCRISPR screenMGAimmune evasionin vivo screen

Sustainable Development Goals

SDG 0: Good health and well-being